Corcept Therapeutics
CORT
#2480
Rank
โ‚ฌ5.59 B
Marketcap
53,36ย โ‚ฌ
Share price
-0.30%
Change (1 day)
129.21%
Change (1 year)

Revenue for Corcept Therapeutics (CORT)

Revenue in 2024 (TTM): โ‚ฌ0.57 Billion

According to Corcept Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.59 Billion. In 2023 the company made a revenue of โ‚ฌ0.43 Billion an increase over the revenue in the year 2022 that were of โ‚ฌ0.37 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Corcept Therapeutics from 2009 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ0.57 B31.69%
2023 โ‚ฌ0.43 B16.48%
2022 โ‚ฌ0.37 B15.93%
2021 โ‚ฌ0.32 B12.32%
2020 โ‚ฌ0.28 B5.16%
2019 โ‚ฌ0.27 B24.57%
2018 โ‚ฌ0.21 B65.52%
2017 โ‚ฌ0.13 B71.62%
2016 โ‚ฌ77.31 M68.11%
2015 โ‚ฌ45.99 M110.66%
2014 โ‚ฌ21.83 M191.11%
2013 โ‚ฌ7.49 M199.98%
2012 โ‚ฌ2.5 M
2011 N/A
2010 N/A-100%
2009 โ‚ฌ0.02 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ83.68 B 13,852.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ45.26 B 7,446.67%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ47.65 B 7,845.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ38.99 B 6,401.15%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ53.09 B 8,752.37%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ59.62 B 9,840.10%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.26 B-55.81%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.23 B-60.48%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ2.62 B 337.96%๐Ÿ‡บ๐Ÿ‡ธ USA